Outcomes of Neonates Born to Mothers With SARS-CoV-2 Infection in Shanghai

NCT05379452 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 236

Last updated 2023-12-29

No results posted yet for this study

Summary

Since March 2022, there are an outbreak of SARS-CoV-2 infection (Omicron) in Shanghai. This cohort study aims to analysis the clinical outcomes of neonates born to mothers with SARS-CoV-2 infection.

Conditions

  • SARS-CoV2 Infection
  • Neonatal Infection
  • Outcomes

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-01-01
Completion
2023-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05379452 on ClinicalTrials.gov